Global Penicillin Active Pharmaceutical Ingredients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Penicillin Active Pharmaceutical Ingredients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. It is an antibiotic extracted from Penicillium. Penicillin belongs to β-lactam antibiotics, and β-lactam antibiotics include penicillin, cephalosporin, carbapenems, monocyclic, and cephalosporins. Penicillin is a very common antibacterial drug. However, an intradermal test must be performed before each use to prevent allergies.
This report focuses on Penicillin Active Pharmaceutical Ingredients.
Penicillin Active Pharmaceutical Ingredients report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Penicillin Active Pharmaceutical Ingredients market is projected to reach US$ 1653.5 million in 2034, increasing from US$ 1827.2 million in 2022, with the CAGR of -1.4% during the period of 2024 to 2034. Demand from For Oral and For Injection are the major drivers for the industry.
Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Penicillin Active Pharmaceutical Ingredients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical
Changsheng Pharma
Aurobindo Pharma
Novartis
ACS Dobfar
Segment by Type
Amoxicillin
Piperacillin
Benzylpenicillin Sodium
Ampicillin
Other
For Oral
For Injection
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Penicillin Active Pharmaceutical Ingredients market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Penicillin Active Pharmaceutical Ingredients, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Penicillin Active Pharmaceutical Ingredients industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Penicillin Active Pharmaceutical Ingredients in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Penicillin Active Pharmaceutical Ingredients introduction, etc. Penicillin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Penicillin Active Pharmaceutical Ingredients market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
This report focuses on Penicillin Active Pharmaceutical Ingredients.
Penicillin Active Pharmaceutical Ingredients report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Penicillin Active Pharmaceutical Ingredients market is projected to reach US$ 1653.5 million in 2034, increasing from US$ 1827.2 million in 2022, with the CAGR of -1.4% during the period of 2024 to 2034. Demand from For Oral and For Injection are the major drivers for the industry.
Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Penicillin Active Pharmaceutical Ingredients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical
Changsheng Pharma
Aurobindo Pharma
Novartis
ACS Dobfar
Segment by Type
Amoxicillin
Piperacillin
Benzylpenicillin Sodium
Ampicillin
Other
Segment by Application
For Oral
For Injection
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Penicillin Active Pharmaceutical Ingredients market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Penicillin Active Pharmaceutical Ingredients, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Penicillin Active Pharmaceutical Ingredients industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Penicillin Active Pharmaceutical Ingredients in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Penicillin Active Pharmaceutical Ingredients introduction, etc. Penicillin Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Penicillin Active Pharmaceutical Ingredients market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.